Last reviewed · How we verify

NCT06317584: CAM

Empowerment-based Complementary and Alternative Medicine (ECAM)

Completed NA Last updated 1 April 2025
What this trial tests

NA trial testing Experimental: Empowerment Application for CAM Health Education in Diabetes in 88 participants. Completed in 3 January 2025.

Timeline
17 May 2024
Primary endpoint
16 August 2024
3 January 2025

Quick facts

Lead sponsorChang Gung University of Science and Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposehealth services research
Enrollment88
Start date17 May 2024
Primary completion16 August 2024
Estimated completion3 January 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung University of Science and Technology

Who can join

Adults 20 to 90, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Other Chang Gung University of Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06317584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing